In 2018, 120,000 Texans are expected to develop cancer, even as advancements in treatment and early detection have led to a decline in cancer deaths. As the cancer landscape continues to change, our physicians share their perspectives on the top five most important trends in cancer this year.
Toppling Type
- The location of cancer tumors is becoming less relevant than what’s inside the molecules of cells that comprise them.
- The Texas Oncology research team has been integral in recent research studies on treating molecular targets rather than just simply traditional cancer subtypes.
No Chemo?
- While chemotherapy is still a main type of therapy, cancer treatment is becoming more targeted at specific gene mutations.
- Innovations like immunotherapy, CAR-T therapy, proton therapy, and new medicines are transforming cancer care.
Big Data = Big Solutions
- Texas Oncology is at the forefront of using big data to improve cancer care, including genetic risk assessment, therapeutic discovery, and improving health services with a focus on patient-centered care.
Surviving and Thriving
- Texas Oncology is delivering innovative cancer treatment to patients – including breakthrough clinical trials and personalized treatments that are more effective and less toxic with better outcomes.
- When treatment ends, Texas Oncology provides patients with a survivorship plan, a roadmap for what lies ahead, helping patients transition into "the new normal."
Patient Power
- Well-informed patients better understand their cancer and their treatment.
- Texas Oncology is taking steps to improve communication with patients about their treatment and more patient participation in decision making for their cancer care.